Physician Consultation and COVID-19 treatment
From diagnosis to therapeutic care in the comfort and privacy of your home
THE IV DOC team has you covered.
THE IV DOC team is administering monoclonal antibody treatments and antiviral therapies
to help prevent hospitalization for COVID-19. Some of these medications are FDA approved, and others are under emergency use authorization (EUA).
All COVID treatments are available in very limited quantities nationwide. Our strict criteria for qualifying is based upon reducing hospitalizations from COVID-19, as full hospitals affect all patients who may need care.
Due to the prevalence of the omicron variant in our community, we are administering Sotrovimab in some states and only Bebtelovimab in all states, as they are the only monoclonal antibody treatments effective against the current variants. This medication is given as an infusion treatment of mild-to-moderate COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.
EUA fact sheet about Sotrovimab
EUA fact sheet about Bebtelovimab
This oral medication is available by prescription only, is filled through our partner Pharmacies.
This oral medication is available by prescription only, and has limited availablity through certain retail pharmacies.